Dyslipidemia Management in Chinese Post Stroke Patients

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to provide current and reliable data of dyslipidimia management together with control situation of blood pressure and glucose for post-stroke patients within 6-12 months from attack, and also the association between patient characteristics and control rate of lipids in this population. It is an non-interventional study, no study specified treatment is required.Approximately 5000 post ischemic stroke patients within 6-12 months from attack will enter into the study. Fifty centres from different regions of China will participate in this study.

Detailed Description
-----------------
This is a multicentre, cross-sectional, observational study, aiming to investigate the prevalence and control situation of dyslipidimia in China post ischemic stroke patients within 6-12 months from attack. Patients will be screened consecutively, eligible subjects will be interviewed by investigator and finish a questionire during the visit. Investigator will collect relevant medical history, physical exam results and lab test results including blood lipid (i.e. Triglyceride, Total Cholesterol, LDL-C, HDL-C) and glucose(HbA1c if available).Approximately 5000 post ischemic stroke patients within 6-12 months from attack will enter into the study. Fifty centres from different regions of China will participate in this study.

Official Title
-----------------
Dyslipidemia Management in Chinese Post Stroke Patients

Conditions
-----------------
Brain Ischemia,Stoke

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Male or female with age ≥ 18 years Post ischemic stroke patients within 6-12 months from attack written informed consent is provided to participant in the study Exclusion Criteria: Significant medical or psychological condition that make patients can not finish the questionnaire independently or with the aids of his/her legal representatives The patient is or will be in another clinical study Previous enrolment in the present study

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| One Group<br>Full Analysis Set (FAS) will be the primary analysis set. All post ischemic stroke patients within 6-12 months from attack (i.e., with inclusion criterion No.2 fulfilled) except the screening failure patients, i.e., those who withdraw from the study once the informed consent is given, will be included in the FAS. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| To observe LDL-C level of China post-stroke patients within 6-12 months from attack | Investigator will collect lab test results including blood lipid (i.e. Triglyceride, Total Cholesterol, LDL-C, HDL-C) during the patient visit. | Up to 12 months | 
| To observe control rate of LDL-C of China post-stroke patients within 6-12 months from attack |  | Up to 12 months |